CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction Nitrosative stress drives heart failure with preserved ejection fraction Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

Clinical Trial2016 Apr;35(4):528-36.

JOURNAL:J Heart Lung Transplant. Article Link

Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol

Heatley G, Sood P, MOMENTUM 3 Investigators. Keywords: HeartMate 3; LVAD; MOMENTUM 3; MagLev; advanced heart failure

FULL TEXT PDF